diagnost tool
sign deal larg fast grow corpor
group reiter buy pt
announc close anoth big contract win time suppli in-
clinic diagnost equip suppli pathway vet allianc high qualiti fast-
grow corpor group consist anim hospit spoke
manag confirm multi-year deal competit win mostli
industri leader updat model time believ
deal help de-risk setup posit compani upsid
acceler blood consum like recent larg new
custom win new product launch scarciti valu last
stand small pure-play anim health diagnost compani wake zts-
abax deal announc reiter buy rate rais pt
use multipl revenue estim discount back
year remind agre pay trail year revenu acquir abax
add qualiti rapidli grow corpor group pathway vet allianc fast-
grow austin texas-bas nation veterinari hospit group clear acquisit
pathway acquir hospit pet vet allianc clinic adopt hska poc
blood diagnost equip perhap time look add imag
pathway appear well-run sophist group pathway major own
morgan stanley global privat equiti whose fund enabl pathway scale
hospit accord sourc
pathway goal make hospit acquisit impli hospit
total end achiev goal pathway alreadi acquir clinic
expect add anoth suspicion pathway
continu tri bolt anoth clinic per year beyond perpetu
term deal disclos said suspect deal similar
typic deal length year petvetcar center deal suspect
like afford pathway hospit flexibl retain legaci
equip estim pathway clinic migrat
time spoke manag indic deal center
around adopt blood-bas instrument requir
imag convers though pathway certainli choos adopt expect
instal start within next day price via reset rental agreement
compar term given mani custom similar margin
believ like take complet instal
setup look de-risk recal analyst day tweak
baselin revenue guid driven rev consum
imag partial off-set y/i ovp believ
today news portend upsid consum growth mainli hit
could provid upsid estim think bigger inflect
come particularli expect take month
complet instal frankli like continu roll-out given
activ pathway
price close busi june
fast-grow compani anim health
diagnost seek take modest us market
share gain expand intern significantli
time
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
launchpad new offer believ pathway vet allianc deal come
ideal time gear host major new product launch instrument
upgrad announc analyst day may plan launch element
 urin sediment analyz element immuno-diagnost analyz
element fecal imag analyz peg
target launch respect
believ major new product add
pathway appear well-fund run strong manag team
includ darin nelson evp acquisit formerli serv svp
sale partnership prior svp busi develop vca
antech help transact anim hospit revenu pathway ceo
dr stephen hadley dvm ms wharton join pathway dr hadley
former vca execut earlier career recent dr hadley serv
bluepearl own mar corp oper emerg specialti vet
hospit across state across us prior bluepearl dr hadley serv
chief strategi offic medvet founder tental capit llc found
director vca specialti anim hospit serv group vice-president vca
buy unchang target price june
diagnost tool
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
buy unchang target price june
diagnost tool
buy unchang target price june
diagnost tool
